Tandem Diabetes Care Inc
(STU:TD5A)
€
29.15
-1.65 (-5.36%)
Market Cap: 1.92 Bil
Enterprise Value: 1.92 Bil
PE Ratio: 0
PB Ratio: 8.66
GF Score: 82/100 Tandem Diabetes Care Inc at Morgan Stanley Healthcare Conference Transcript
Sep 11, 2019 / 02:30PM GMT
Release Date Price:
€56.49
(+0.50%)
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate
Hi, we're on the clock, so I think we can go ahead and get started.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
All right.
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate
Good morning, everyone. My name is Marissa Bych, I am a medical technology research associate on David Lewis' team at Morgan Stanley. And so I'm with Tandem Diabetes this morning. We have John Sheridan, the President and CEO; and we also have Leigh Vosseller, the EVP and CFO of the company with us. Very excited to have you both with us today.
Questions & Answers
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate
If we could start off, what is Tandem, briefly for those who may be less familiar? And then talk to us at a high level about what has changed for your company? Over the past 1 to 2 years, you've launched a new product
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot